The expression of KRAS, MAPK1, NRAS, and PTEN was significantly upregulated in the tubulointerstitial region of patients with hypertensive nephropathy compared with healthy living donors (Figure 8A, left panel). Here, MAPK1 is linked to hypertensive nephropathy.